T.P. DEMICHEVA

 Perm State Medical Academy named after E.A. Wagner, Perm

 Contact details:

Demicheva T.P. — Associate Professor of the Department of Endocrinology and Clinical Pharmacology

Address: 26 Petropavlovskaya St., Perm, Russian Federation, 614990, tel.: +7-912-582-19-50, e-mail: demich-perm@mail.ru

 The purpose — to give clinical and metabolic characteristics of patients with type 2 diabetes who survived and died from COVID-19.

Material and methods. The object of observation: patients (159 patients aged 40 to 90 years old) hospitalized in a repurposed infectious diseases hospital for the treating patients with COVID-19. Two groups were distinguished: patients with type 2 diabetes mellitus who survived (group 1a) and died from COVID-19. The design of the work involved a comparative assessment of the initial clinical and metabolic parameters in patients of both groups.

Results. There were no statistically significant differences in age, BMI, duration of the outpatient phase, cholesterol, troponin, APTT, PTT, fibrinogen between the study groups. Patients with type 2 diabetes who died from COVID-19 showed a higher level of glycemia, a three times higher area of lung damage, reduced saturation, a more pronounced inflammatory reaction, manifested as an increase in serum ferritin (2.7 times), C-reactive protein — 1.5 times and immune suppression. The level of D—dimer was 2.7 times higher, the aaactivity of liver enzymes was 1.5 times higher, the number of lymphocytes was reduced 2 times.

Conclusion. A high level of mortality under the maximum fulfillment of the requirements for the quality of diagnosis and treatment indicates the comorbidity severity and the need to refine the treatment tactics of this category of patients.

Key words: patients with type 2 diabetes mellitus, survivors, deceased, new coronavirus infection, clinical and metabolic characteristics.

REFERENCES

1. Simmonet A., Chetboun M., Poissy J. et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity (SilverSpring), 2020, available at: https://onlinelibrary.wiley.com/doi/epdf/10.1002/oby.22831
2. Epidemiology Working Group for Ncip Epidemic Response. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi, 2020, vol. 41 (2), rr. 145–151. DOI: 10.3760/cmaj.issn.0254-6450.2020.02.003
3. Guan W.J., Ni Z.Y., Hu Y. et al. China medical treatment expert group for COVID-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med, 2020, vol. 382 (18), pp. 1708–1720. DOI: 10.1056/NEJMoa2002032
4. Glybochko P.V., Fomin V.V., Avdeev S.N., Moiseev S.V., Yavorovskiy A.G. et al. Clinical characteristics of 1007 patients with severe SARS-COV-2 pneumonia who needed respiratory support. Klinicheskaya farmakologiya i terapiya, 2020, vol. 29, no. 2, pp. 21–29 (in Russ.). DOI: 10.32756/0869-5490-2020-2-21-29
5. Gupta R., Ghosh A., Singh A.K., Misra A. Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes Metab Syndr, 2020, vol. 14 (3), pp. 211–212. DOI: 10.1016/j.dsx.2020.03.002
6. Belikina D.V., Nekrasova T.A., Malysheva E.S. et al. COVID-19 and diabetes mellitus: course features, outcomes, role of inflammatory and glycemic disorders. Meditsinskiy al’manakh, 2021, no. 2, p. 67 (in Russ.), available at: https://cyberleninka.ru/article/n/covid-19-i-saharnyy-diabet-osobennosti-techeniya-ishody-rol-vospalitelnyh-i-glikemicheskih-narusheniy (accessed on: 17.03.2023).
7. Demidova T.Yu., Lobanova K.G., Perekhodov S.N., Antsiferov M.B., Oynotkinova O.Sh. Clinical and laboratory characteristics of patients with COVID-19 and concomitant type 2 diabetes mellitus. Kardiovaskulyarnaya terapiya i profilaktika, 2021, vol. 20, no. 1, p. 2750 (in Russ.). DOI: 10.15829/1728-8800-2021-2750
8. Shi S. et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol, 2020.

9. Bode B., Garrett V., Messler J. et al. Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States. J. Diabetes Sci. Technol, 2020, vol. 14 (4), pp. 813–21. DOI: 10.1177/1932296820924469
10. Pretorius L., Thomson G.J.A., Adams R.C.M. et al. Platelet activity and hypercoagulation in type 2 diabetes. Cardiovasc Diabetol, 2018, vol. 17, p. 141. DOI: 10.1186/s12933-018-0783